Marjan Industria e Comercio ltda   Report issue

For profit Phase 3
Founded: Sao Paulo Brazil (1961)
Status: No NME R&D (1961)

Organization Overview

First Clinical Trial
2009
NCT00794456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 3)

Communicable Diseases (Phase 3)

Constipation (Phase 3)

Infections (Phase 3)

Vaginosis, Bacterial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 8